49,565 Shares in Guardian Pharmacy Services, Inc. $GRDN Bought by Inspire Investing LLC

Inspire Investing LLC bought a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) in the 1st quarter, Holdings Channel reports. The institutional investor bought 49,565 shares of the company’s stock, valued at approximately $1,867,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of GRDN. Invesco Ltd. boosted its holdings in shares of Guardian Pharmacy Services by 35.6% during the 4th quarter. Invesco Ltd. now owns 14,175 shares of the company’s stock valued at $427,000 after purchasing an additional 3,718 shares during the last quarter. XTX Topco Ltd bought a new stake in shares of Guardian Pharmacy Services in the fourth quarter worth about $348,000. Valiant Capital Management L.P. increased its holdings in shares of Guardian Pharmacy Services by 15.8% in the fourth quarter. Valiant Capital Management L.P. now owns 1,232,463 shares of the company’s stock worth $37,085,000 after purchasing an additional 167,741 shares during the last quarter. Susquehanna Portfolio Strategies LLC purchased a new stake in shares of Guardian Pharmacy Services in the fourth quarter worth about $333,000. Finally, Occudo Quantitative Strategies LP lifted its position in shares of Guardian Pharmacy Services by 94.8% in the fourth quarter. Occudo Quantitative Strategies LP now owns 31,266 shares of the company’s stock worth $941,000 after buying an additional 15,218 shares in the last quarter.

Wall Street Analysts Forecast Growth

GRDN has been the subject of several research analyst reports. Truist Financial raised their price target on Guardian Pharmacy Services from $43.00 to $47.00 and gave the company a “buy” rating in a report on Wednesday, June 17th. UBS Group reaffirmed a “buy” rating on shares of Guardian Pharmacy Services in a report on Thursday, March 12th. Weiss Ratings downgraded Guardian Pharmacy Services from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 11th. Oppenheimer raised their target price on shares of Guardian Pharmacy Services from $38.00 to $43.00 and gave the company an “outperform” rating in a report on Thursday, May 7th. Finally, Bank of America boosted their price target on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a research report on Wednesday, June 17th. Seven analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $42.83.

Guardian Pharmacy Services Trading Up 3.7%

Shares of NYSE:GRDN opened at $41.92 on Wednesday. Guardian Pharmacy Services, Inc. has a 12 month low of $19.30 and a 12 month high of $44.00. The company has a 50-day moving average price of $38.93 and a 200 day moving average price of $35.14. The company has a market cap of $2.09 billion, a price-to-earnings ratio of 50.50, a PEG ratio of 2.65 and a beta of 0.08.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.05. Guardian Pharmacy Services had a return on equity of 30.72% and a net margin of 3.64%.The company had revenue of $336.60 million for the quarter, compared to analysts’ expectations of $329.89 million. During the same period in the previous year, the firm posted $0.22 earnings per share. The firm’s revenue for the quarter was up 2.2% on a year-over-year basis. As a group, equities analysts forecast that Guardian Pharmacy Services, Inc. will post 1.18 EPS for the current year.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.